Evaluation of the effects of amiodarone and amiodarone+dobutamine on survival in tilmicosin-induced toxicity by electrocardiography and biochemical parameters Survival rate in tilmicosin toxicity
Abstract
Tilmicosin shows different degrees of cardiotoxic effect in various animal species depending on the route of administration and dose. We aimed to determine the effects of amiodarone and amiodarone+dobutamine treatments on tilmicosin cardiotoxicity and survival time. 18 healthy goats were divided into tilmicosin, tilmicosin+amiodarone and tilmicosin+amiodarone+dobutamine groups. After drug administrations, the survival times of the animals in all groups were recorded. In addition, blood was drawn from the animals just before they died. Haemogram, troponin I, CK-MB and other biochemical parameters were measured in all blood samples. Prolonged survival was observed in the treatment groups compared to the tilmicosin group. In the treatment groups, decreases in haemogram parameters, albumin, total protein and cholesterol levels caused by tilmicosin could not be prevented, while the increase in troponin I level was prevented. In conclusion, while cardiotoxicity due to high troponin from tilmicosin was prevented, the survival rate was not affected in both treatment groups, and the survival time was extended at differing rates. In case of accidental or deliberate overdose of tilmicosin in animals, in addition to the use of amiodarone+dobutamine, the survival time may be prolonged, and the success may increase if the necessary symptomatic treatments and equipment support are available.
Article Details
- Zitationsvorschlag
-
Coskun, D., ider, M., naseri, A., Dik, B., Bahcivan, E., Tras, B., & Er, A. (2024). Evaluation of the effects of amiodarone and amiodarone+dobutamine on survival in tilmicosin-induced toxicity by electrocardiography and biochemical parameters : Survival rate in tilmicosin toxicity. Journal of the Hellenic Veterinary Medical Society, 75(1), 7081–7088. https://doi.org/10.12681/jhvms.34146
- Ausgabe
- Bd. 75 Nr. 1 (2024)
- Rubrik
- Research Articles
Dieses Werk steht unter der Lizenz Creative Commons Namensnennung - Nicht-kommerziell 4.0 International.
Authors who publish with this journal agree to the following terms:
· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Downloads
Keine Nutzungsdaten vorhanden.
Literaturhinweise
Bacq ZM, Blakeley AGH, Summers RJ (1976) Theeffects of amiodarone, an α and β receptorantagonist, on adrenergictransmission in thecatspleen. BiochemPharmacol25:1195-1199.
Cetin E (2019) Protectiveeffect of ghrelinagainsttilmicosin-inducedleftventriculardysfunction in rats. Can J PhysiolPharmacol97:407-412.
Chen YN, Wei JR, Zeng LJ, Wu MY (1999) Monitoring of cardiactroponin I in patientswithacuteheartfailure. AnnClinBiochem 36(Pt4):433-437.
Christodoulopoulos G, Warnick LD, Papaioannou N, Fthenakis GC (2002) Tilmicosin administration to young lamb swith respiratoryinfection: safety and efficacy considerations. J VetPharmacolTher 25: 393-397.
Christodoulopoulos G (2009) Adverseoutcome of usingtilmicosin in a
lambwithmultipleventricularseptaldefects. Can Vet J 50: 61-63.
Coskun Y, Golen I, Ondes S, Erdogdu AT (2012) Poisoningcasecausedbytilmicosin in goats. J Bornova VetSci34:39-42.
CVMP (2009) Europeanpublic MRL assessmentreport (EPMAR):Tildipirosin. EMA/CVMP/709377/2009. VeterinaryMedicinesand Product Data Management, London, United Kingdom.
Dias da Silva V, Gnecchi-Ruscone T, Lavelli B, Bellina V, Manzella D, Porta A, Malliani A, Montano N (2002) Oppositeeffects of iv amiodarone on cardiovascularvagalandsympatheticefferentactivities in rats. Am J PhysiolRegulIntegrCompPhysiol 283:543-548.
Diaz JH (2014) Atlas of Human PoisoningandEnvenoming, 2nd ed., CRC Press.
El Sayed MG, El-Komy AA, Mobarez EA, Afify AE (2016) Pharmacokinetics of tilmicosin in healthyandvaccinatedlactatinggoatsanditseffects on humoralimmuneresponse in vaccinatedlactatinggoats.
WJPPS 5:2337-2350.
Elazab MFA, Gomaa GM, Abdo W (2014) Protectiveeffect of S-methylcysteineagainsttilmicosin-inducedcardiotoxicity in rats. Pak Vet J
:337-340.
Elsayed M, Elkomy A, Aboubakr M, Morad M (2014) Tissueresidues,
hematologicalandbiochemicaleffects of tilmicosin in broilerchicken.
VetMedInt ID:502872.
Er A, Tras B, Cetin G, Dik B (2014) Amiodaronemaypreventthetilmicosin-causedlethaltoxicity. ActaScientiaeVeterinariae42:1187.
Gheith I, El-Mahmoudy A, Elmajdoub A, Awidat S (2015) Pharmacovigilance of tilmicosin in mice. ActaSciVet43:1318.
Giguère S, Prescott JF, Dowling PM (2013) Antimicrobialtherapy in veterinarymedicine, 5th ed., John Wiley&Sons.
Ginwalla M, Tofovic DS (2018) Currentstatus of inotropes in heartfailure.
Heart Fail Clin 14(4): 601-616.
Hanton G, Nahas K, Priou C, Rabemampianina Y, Baneux P (2001) The
QT interval in thedogECG:Importance in preclinicaltoxicologyandrelationshiptoheart rate. ToxicolMethods11:21-40.
Heidenreich PA, Keeffe B, McDonald KM, Hlatky MA (2002) Overview
of randomizedtrials of antiarrhythmicdrugsanddevicesfortheprevention of suddencardiacdeath. AmHeart J 144:422-430.
Jordan WH, Byrd RA, Cochrane RL, Hanasono GK, Hoyt JA, Main BV,
Meyehoff RD, Sarazan RD (1993) A review of thetoxicology of theantibiotic MICOTIL300. Vet Hum Toxicol35:151-158.
Kayaalp SO (2009) Sympathomimeticdrugs, In: MedicalPharmacology.
Ankara, Hacettepe-Tas: pp 972-994.
Kodama I, Kamiya K, Toyama J (1997) Cellular electropharmacology of
amiodarone. CardiovascRes 35(1):13-29.
Lust EB, Barthold C, Malesker MA, Wichman, TO (2011) Human healthhazards of veterinarymedications:informationforemergencydepartments. J EmergMed40:198-207.
Main BW, Means JR, Rinkema LE, Smith WC, Sarazan RD (1996)
Cardiovasculareffects of themacrolideantibiotictilmicosin, administeredaloneand in combinationwithpropranololordobutamine, in consciousunrestraineddogs. J VetPharmacolTher19:225-232.
Papich M (2016) SaundersHandbook of VeterinaryDrugs: Small andLargeAnimal, 4th ed.,Saunders.
Perkins MW, Dasta JF, Reilley TE, Halpern P (1989) Intraoperativecomplications in patientsreceivingamiodarone: Characteristicsand risk
factors. DICP 23:757-763.
Ramadan A (1997) Pharmacokinetics of tilmicosin in serum andmilk of
goats. ResVetSci62:48-50.
Vallet B, Dupuis B, Chopin C (1991) [Dobutamine: mechanisms of actionanduse in acutecardiovascularpathology]. AnnCardiolAngeiol
(Paris) 40:397-402.
Vassallo P, Trohman RG (2007) Prescribingamiodarone: an evidence-basedreview of clinicalindications. JAMA 298:1312-1322.
Yapar K, Kart A, Karapehlivan M (2006) Effects of differentdoses of tilmicosin on somebiochemicalparametersandantioxidantstatus in serum
andcardiactissues in mice. B Vet I Puławy50:605-608.
Yazar E, Altunok V, Elmas M, Tras B, Bas AL, Ozdemir V (2002) Theeffect of tilmicosin on cardiacsuperoxidedismutaseandglutathioneperoxidaseactivities. J VetMed B InfectDisVetPublicHealth49:209-210.
Yazar E, Altunok V, Elmas M, Tras B, Bas AL, Ozdemir V (2021) Effect
of tilmicosin on cardiacmuscleand serum creatinekinasesactivitiesand serum total protein level in healthymaleBalb/C mice. RevMedVet-Toulouse 152:881-883.
Youssef MA, Ibrahim HM, Farag ESM, El-Khodery SA (2016) Effects of
tilmicosinphosphateadministration on echocardiographicparameters
in healthydonkeys (Equusasinus): an experimentalstudy. J EquineVetSci38:24-29.
Zweers-Zeilmaker WM, Batzias J, Maas RF, Horbach GJ, vanMiert AS,
Witkamp RF (1996) Invitroand in vivooxidativebiotransformation in
the West-Africandwarfgoat (Caprushircusaegagrus):substrateactivitiesandeffects of inducers. Xenobiotica26:1131-1141
